Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500105477Phase 4Recruiting
Phase 4, randomised trial of tetracaine, oxybuprocaine and dyclonine in Lithiasis, ureterolithiasis, nephrolithiasis and 2 more (3 arms), sponsored by International Zhuang Medical Hospital of Guangxi University of Traditional Chinese Medicine. Primary endpoint: Catheter-related bladder discomfort (CRBD). Started Jul 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500105477.